We've Got Hollywood Covered

Pharma Bro Martin Shkreli Calls Securities Fraud Case ‘Silly Witch Hunt’

The former hedge fund manager is currently on trial

Martin Shkreli, the outspoken 34-year-old pharmaceutical exec and hedge fund manager who is currently on trial for securities fraud, clapped back at prosecutors in a Trump-esque way in a Thursday Facebook post, calling the case against him a “silly witch hunt.”

“My case is a silly witch hunt perpetrated by self-serving prosecutors,” Shkreli wrote on Facebook. “Thankfully my amazing attorney sent them back to junior varsity where they belong. Drain the swamp. Drain the sewer that is the DOJ. MAGA.”

Those “self-serving prosecutors” have alleged that Skhreli lied to investors in two hedge funds and pharmaceutical company Retrophin, for which Shkreli served as CEO, over a five year period. His attorneys argue that Shkreli’s victims actually ended up making money despite issues with his hedge funds.

Shkreli, who was permanently banned from Twitter earlier this year, has been a polarizing figure on social media well before the trial. He first came to prominence when another company he ran, Turing Pharmaceuticals, acquired the rights to a drug and raised its price from $13.50 to $750 a pill, which generated outrage and led to him being subpoenaed by Congress to testify about drug pricing.

Shkreli is also known in the music world for being the buyer of the Wu-Tang Clan album “Once Upon a Time in Shaolin,” of which only one copy was ever produced — and was acquired by the pharma exec for $2 million.